Syndromic Multiplex Diagnostics
A Global Strategic Business Report
MCP35854
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (55)
3
CXO5
VICE PRESIDENT10
DIRECTOR25
MANAGER12
MARKETING
REQUEST FULL-STACK INDEX
Includes 350+ pages validated sources
QUESTIONNAIRE
EXECUTIVES
DATA ROOM
HIGHLIGHTS & REPORT INDEX
Global Syndromic Multiplex Diagnostics Market to Reach US$3.8 Billion by 2030
The global market for Syndromic Multiplex Diagnostics estimated at US$2.7 Billion in the year 2024, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Respiratory, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Gastrointestinal segment is estimated at 7.4% CAGR over the analysis period.
The U.S. Market is Estimated at US$736.4 Million While China is Forecast to Grow at 8.7% CAGR
The Syndromic Multiplex Diagnostics market in the U.S. is estimated at US$736.4 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$748.2 Million by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.
Global "Syndromic Multiplex Diagnostics" Market – Key Trends & Drivers Summarized
How Is Multiplexing Revolutionizing Rapid Disease Detection?
In an era of rapidly evolving pathogens and increasing demand for point-of-care testing, syndromic multiplex diagnostics has emerged as a transformative force in clinical diagnostics. Unlike traditional one-pathogen-per-test models, syndromic panels enable simultaneous detection of multiple pathogens responsible for a specific clinical syndrome, such as respiratory infections, gastrointestinal diseases, or central nervous system disorders. The technology has proven vital in emergency care settings where speed and accuracy can determine treatment outcomes. Recent advancements have reduced test turnaround times to under an hour, facilitating timely clinical decisions. COVID-19 served as an unprecedented catalyst, heightening global awareness and adoption of multiplex testing. Regulatory bodies like the FDA and CE have fast-tracked approvals for multiplex diagnostic panels, encouraging wider clinical application.
Multiplex diagnostics are particularly critical in pediatric care and immunocompromised patient populations, where co-infections are common and symptoms may be atypical. The ability to identify co-infections through a single test has drastically reduced the number of unnecessary treatments, helping combat antimicrobial resistance. Emerging market players are innovating with miniaturized platforms, reducing device footprint and increasing accessibility in decentralized settings. Notably, companies are leveraging AI to enhance interpretation algorithms and provide real-time decision support. Cloud-based data integration with hospital information systems is another major breakthrough, enabling longitudinal patient monitoring and epidemiological tracking. With growing demand from low-resource healthcare systems, cost-effective portable models are being developed to bridge diagnostic gaps in remote regions.
Can Automation and AI Bridge Laboratory Capacity Gaps?
The role of artificial intelligence and automation in syndromic multiplex diagnostics is gaining considerable momentum. Advanced platforms now incorporate robotic pipetting, integrated thermal cyclers, and automated result reporting, greatly reducing human intervention and minimizing error rates. AI-driven systems enhance pathogen identification by parsing through complex data sets to interpret ambiguous results more accurately. These developments have significantly expanded throughput, making large-scale screening programs feasible during epidemics or in high-volume clinical laboratories. Machine learning is also aiding in continuous software optimization by analyzing false-positive and false-negative rates over time to refine algorithm accuracy.
Telemedicine integration has further propelled the utility of syndromic testing, allowing healthcare providers to initiate and interpret tests remotely. In particular, this has boosted use cases in mobile health units and rural diagnostics where lab specialists are scarce. Meanwhile, the scalability of syndromic systems is attracting attention from military and disaster response organizations, who value portability and efficiency in austere environments. Start-ups and tech companies are entering the space aggressively, often partnering with biotech firms to co-develop hybrid platforms that integrate diagnostics with treatment planning. Data security and interoperability are now central to innovation, with blockchain and decentralized ledgers being explored to ensure test result integrity in shared ecosystems.
What’s Driving Adoption Beyond Infectious Diseases?
While syndromic multiplex diagnostics has traditionally focused on infectious diseases, recent breakthroughs are expanding its use into non-infectious realms such as oncology, pharmacogenomics, and autoimmune disorders. Multiplex panels are now being developed to assess genetic markers, tumor mutations, and immune response indicators, opening up new frontiers in personalized medicine. Cancer profiling using multiplex PCR or next-gen sequencing panels allows clinicians to tailor treatments based on comprehensive tumor biology in a single run. Similarly, autoimmune panels help diagnose overlapping syndromes like lupus and rheumatoid arthritis more effectively by detecting multiple biomarkers simultaneously.
In neonatal intensive care units (NICUs), multiplex testing is helping to rapidly diagnose congenital infections or metabolic disorders, ensuring timely interventions. In the pharmacogenomics sector, these tests are used to evaluate patient-specific responses to drugs, aiding in dose optimization and reducing adverse drug reactions. This is especially pertinent in chronic disease management where polypharmacy is common. There is also a growing interest in combining syndromic diagnostics with wearable health tech to create proactive monitoring systems, which could redefine chronic disease tracking and relapse prediction. Pharmaceutical companies are collaborating with diagnostic labs to integrate multiplex testing into clinical trials to stratify patients and monitor responses more effectively.
The Growth in the Syndromic Multiplex Diagnostics Market Is Driven by Several Factors…
The growth in the syndromic multiplex diagnostics market is driven by several factors rooted in technological advancements, healthcare infrastructure trends, and evolving clinical practices. The most significant driver is the increasing demand for rapid, comprehensive diagnostic solutions in both hospital and outpatient settings. As healthcare systems prioritize efficiency, multiplex platforms are replacing traditional culture and single-pathogen tests, reducing the diagnostic burden on laboratories. Innovations in microfluidics, lab-on-chip platforms, and integrated biosensors have enabled the miniaturization of diagnostic systems, increasing their availability in decentralized and rural locations. The proliferation of infectious diseases—coupled with rising antibiotic resistance—has intensified the need for tests that can distinguish between viral and bacterial etiologies swiftly.
End-use demand from emergency departments, ICUs, and ambulatory clinics continues to rise, with particular emphasis on respiratory, gastrointestinal, and sexually transmitted infections. Consumer behavior is also evolving, with increasing public awareness of early diagnosis and preventive screening. This is further supported by government-led screening programs and reimbursement policies, especially in North America and Europe. Pediatric and geriatric populations—both vulnerable to rapid disease progression—are key demographics driving adoption. Additionally, global health initiatives in emerging markets are deploying multiplex diagnostics in humanitarian and pandemic preparedness programs. Finally, strategic investments by major diagnostic players and rising collaborations between public health agencies and diagnostic developers are accelerating product pipelines, ensuring a robust and competitive market landscape.
SCOPE OF STUDY
The report analyzes the Syndromic Multiplex Diagnostics market by the following Segments, and Geographic Regions/Countries:
Segments:
Type (Respiratory, Gastrointestinal, Central Nervous System, Other Types); End-Use (Hospitals, Diagnostics Laboratories, Other End-Uses).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..
SELECT PLAYERS
Abbott Laboratories; Accelerate Diagnostics; Ador Diagnostics; Akonni Biosystems; Alveo Technologies; Applied BioCode; Ayoxxa Biosystems; Baebies; Beckman Coulter Diagnostics; Becton, Dickinson and Company (BD); Biocartis; BioFire Diagnostics (bioMérieux SA); Bio-Rad Laboratories, Inc.; Cepheid (A subsidiary of Danaher); Curetis (A subsidiary of OpGen, Inc.); GenMark Diagnostics; Hologic, Inc.; Roche Diagnostics; Seegene Inc.; Thermo Fisher Scientific Inc.;
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| World Market Trajectories |
| How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind |
| Syndromic Multiplex Diagnostics – Global Key Competitors Percentage Market Share in 2025 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 34 Players Worldwide in 2025 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Integration of Syndromic Panels in Emergency Care Propels Market Growth |
| Rising Demand for Rapid, Point-of-Care Testing Accelerates Technology Adoption |
| Increased Incidence of Multi-Pathogen Infections Spurs Adoption of Multiplex Solutions |
| Growing Antimicrobial Resistance Strengthens Business Case for Syndromic Testing |
| Automation and Workflow Efficiency in Labs Drives Syndromic Diagnostic Uptake |
| Regulatory Push for Early Disease Detection Expands Market Opportunities |
| Miniaturization and Portability of Devices Drive Penetration in Remote Settings |
| Hospital Consolidation Trends Throw the Spotlight on Integrated Diagnostic Platforms |
| AI Integration in Diagnostic Decision Support Spurs Innovation in Test Panels |
| Expanding Applications in Veterinary and Food Safety Diagnostics Fuel Market Growth |
| Increased Reimbursement Support Across Developed Markets Drives Adoption |
| Rising Awareness Among Clinicians and Patients Accelerates Utilization |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Syndromic Multiplex Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030 |
| World Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Syndromic Multiplex Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Syndromic Multiplex Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Respiratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Respiratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Respiratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Gastrointestinal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Central Nervous System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Central Nervous System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Central Nervous System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Diagnostics Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Diagnostics Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Diagnostics Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Syndromic Multiplex Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| JAPAN |
| Syndromic Multiplex Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| CHINA |
| Syndromic Multiplex Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| EUROPE |
| Syndromic Multiplex Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Syndromic Multiplex Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Syndromic Multiplex Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| FRANCE |
| Syndromic Multiplex Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| GERMANY |
| Syndromic Multiplex Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| UNITED KINGDOM |
| Syndromic Multiplex Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| SPAIN |
| Spain Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Spain Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| RUSSIA |
| Russia Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Russia Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| ASIA-PACIFIC |
| Syndromic Multiplex Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Syndromic Multiplex Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Syndromic Multiplex Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| AUSTRALIA |
| Syndromic Multiplex Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E) |
| Australia Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Australia Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| INDIA |
| Syndromic Multiplex Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E) |
| India Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| India Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| SOUTH KOREA |
| South Korea Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| South Korea Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| LATIN AMERICA |
| Syndromic Multiplex Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E) |
| Latin America Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Syndromic Multiplex Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Syndromic Multiplex Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| ARGENTINA |
| Argentina Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Argentina Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| BRAZIL |
| Brazil Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Brazil Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| MEXICO |
| Mexico Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Mexico Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| REST OF LATIN AMERICA |
| Rest of Latin America Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Rest of Latin America Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| MIDDLE EAST |
| Syndromic Multiplex Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E) |
| Middle East Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Syndromic Multiplex Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Syndromic Multiplex Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| IRAN |
| Iran Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Iran Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| ISRAEL |
| Israel Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Israel Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| SAUDI ARABIA |
| Saudi Arabia Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Saudi Arabia Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| UNITED ARAB EMIRATES |
| UAE Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| UAE Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| REST OF MIDDLE EAST |
| Rest of Middle East Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Rest of Middle East Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
| AFRICA |
| Syndromic Multiplex Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E) |
| Africa Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Syndromic Multiplex Diagnostics by Type - Respiratory, Gastrointestinal, Central Nervous System and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Syndromic Multiplex Diagnostics by Type - Percentage Breakdown of Value Sales for Respiratory, Gastrointestinal, Central Nervous System and Other Types for the Years 2015, 2025 & 2030 |
| Africa Recent Past, Current & Future Analysis for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Syndromic Multiplex Diagnostics by End-Use - Hospitals, Diagnostics Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Syndromic Multiplex Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Laboratories and Other End-Uses for the Years 2015, 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]